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To the Editor:  Baylisascaris 
procyonis roundworms are common 
parasites of raccoons (Procyon lotor) 
in several regions of North America, 
Europe, and Asia. These parasites are 
increasingly recognized as a cause of 
larva migrans in humans, an infection 
that often results in severe neurologic 
sequelae or death. In addition, larva 
migrans has been documented in ≈90 
species of wild and domestic birds 
and mammals. In the United States, B. 
procyonis roundworms are most prev-
alent in the midwestern, northeastern, 
and Paciﬁ   c western states. Numer-
ous surveillance studies have been 
conducted in the southeastern United 
States, and B. procyonis roundworms 
are most common in the mountain-
ous regions of Virginia, Kentucky, 
and West Virginia (1–4). Geographic 
expansion of B. procyonis round-
worms has been recently documented 
in Georgia. In 2002, 22% of raccoons 
sampled in DeKalb County, Georgia, 
a highly urbanized area near Atlanta, 
were positive for the parasite (5), and 
recently, 10% of raccoons sampled in 
Clarke County, Georgia, were positive 
(6). Whether this expansion is due to 
natural spread of the parasite among 
raccoons or to translocations of infect-
ed raccoons into naive areas is unclear. 
We document expansion of B. procyo-
nis roundworms into northwestern and 
southeastern Florida. 
In 2006 and 2007, nine ascarids 
(>3 inches) were collected from the 
feces of an unrecorded number of rac-
coons admitted to a rehabilitation cen-
ter in northern Florida. In September 
2008, December 2009, and June 2010, 
one ascarid each was found in the 
feces of a 4- and a 6-month-old rac-
coon from Leon County, Florida, and 
a 6-month-old raccoon from Wakulla 
County, Florida, after routine treat-
ment with pyrantel pamoate (20 mg/
kg). In July 2010, a juvenile (6-month-
old) raccoon from Broward County, 
Florida, which had been admitted to 
a rehabilitation center, passed several 
ascarids (2 collected for testing) in its 
feces after ivermectin treatment (0.2 
mg/mL) for mange. The 14 ascarids 
were preserved in 70% ethanol, and 
adult males were identiﬁ  ed as Bay-
lisascaris spp. on the basis of their 
morphologic characteristics (perianal 
rough patches). The ascarids were 
subsequently conﬁ  rmed as B. procyo-
nis by sequence analysis of the 5.8S 
rRNA gene or the internal transcribed 
spacer (ITS)-1 and ITS-2 regions 
(7,8). The complete sequences of the 
5.8S rRNA gene and ITS-2 region 
from 2 ascarids from northern Flori-
da and 1 from southern Florida were 
identical to B. procyonis sequences 
(GenBank accession nos. AJ001501 
and AB051231, respectively). ITS-1 
sequences from the 2 ascarids from 
northern and southern Florida were 
99.1% (424/428; AB053230) to 100% 
identical (AJ00745 and ascarids from 
Georgia, Kentucky, and Texas [6]), re-
spectively, to B. procyonis sequences.
Several previous studies did not 
detect  B. procyonis roundworms in 
raccoons or latrine sites in central 
Florida (n = 51 from Glades, High-
lands, Hillsborough, and Orange 
counties), southern Florida (n = 90 
from around Miami and n = 64 fecal 
samples on Key Largo), and numer-
ous counties throughout Florida (n 
= 177) (1,3,9). Historically, B. pro-
cyonis roundworms have been absent 
throughout most of the Southeast, but 
the parasite was recently detected in 
north-central Georgia (5,6). How the 
species became established in Florida 
remains unclear. Establishment could 
have resulted from natural dispersal of 
infected raccoons from B. procyonis–
endemic areas; however, recent exam-
ination of several raccoon populations 
in southern Georgia failed to detect 
such infections (6). Alternatively, the 
parasites could have been introduced 
from the movement of infected rac-
coons, exotic pets (e.g., kinkajou [Po-
tos ﬂ  avus]), or natural wildlife inter-
mediate hosts (1). 
Additionally, because domestic 
dogs can serve as deﬁ  nitive hosts, an 
infected dog from a B. procyonis–en-
demic area may have passed eggs into 
the environment (1). Veterinarians in 
Florida should be aware of this pos-
sible zoonosis and carefully examine 
ascarid eggs detected in fecal speci-
mens because B. procyonis–infected 
dogs often have mixed infections with 
Toxocara canis,  Toxascaris leonina, 
or both, which have morphologically 
similar eggs (1). Physicians, veterinar-
ians, and wildlife biologists in Florida 
should be aware of this serious patho-
gen and the likelihood its range will 
increase, as highlighted by the recent 
detection of B. procyonis roundworms 
in a kinkajou from southern Florida 
(K.P. Kazacos et al., unpub. data).
This study also highlights the 
importance of wildlife rehabilitation 
centers as resources for the study of 
wildlife/zoonotic diseases. Animals 
admitted to rehabilitation centers are 
often ill or injured, which may in-
crease pathogen shedding or transmis-
sion. Additionally, young raccoons are 
likely to be infected with B. procyonis 
roundworms, and kits as young as 3 
months of age can be patent. Numer-
ous fatal B. procyonis larva migrans 
infections have occurred among ani-
mals in rehabilitation centers and zoo-
logical parks. These infections were 
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likely acquired when animals were 
housed in enclosures previously oc-
cupied by infected raccoons or when 
bedding or food became contaminated 
with  B. procyonis–infected raccoon 
feces. In B. procyonis–endemic areas, 
cages used to house raccoons should 
be thoroughly decontaminated by 
ﬂ  aming, or cages should be dedicated 
for use by raccoons. Because B. pro-
cyonis roundworms can spread to other 
animals, persons in contact with rac-
coons should be alert to potential trans-
mission routes and apply appropriate 
biosecurity procedures.
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Vibrio cholerae O1 
Variant with 
Reduced 
Susceptibility to 
Ciproﬂ  oxacin, 
Western Africa 
To the Editor: Many variants of 
choleragenic vibrios have emerged 
since the beginning of the seventh 
pandemic, indicating continuous evo-
lution of this pathogenic agent. Varia-
tions occur mainly in genetic determi-
nants of virulence and antimicrobial 
drug susceptibility. In September–Oc-
tober 2009, concurrent outbreaks of 
acute watery diarrhea in northeastern 
Nigeria (4,559 cases) and northern 
Cameroon (696 cases) were inves-
tigated by state ministries of health. 
We report reduced sensitivity to cipro-
ﬂ  oxacin in Vibrio cholerae O1 strains 
and the atypical cholera toxin B (ctxB) 
genotype of these strains.
In September–October 2009, 
stool specimens from patients in Ni-
geria were collected on ﬁ  lter  paper, 
moistened with sterile physiologic 
saline, and sent at room temperature 
to the National Reference Center for 
Vibrios and Cholera at the Institut Pas-
teur (Paris, France). Ten V. cholerae 
O1 biotype El Tor serotype Ogawa 
strains were isolated and identiﬁ  ed 
by using standard procedures. Con-
currently in Cameroon, 9 V. cholerae 
O1 Ogawa strains isolated from pa-
tient stool samples by the bacteriol-
ogy laboratory of the Pasteur Center 
(Garoua, Cameroon) were sent to the 
National Reference Center for Vibrios 
and Cholera.
All strains were tested for antimi-
crobial susceptibility by MIC determi-
nation to tetracycline, trimethoprim/
sulfamethoxazole, sulfonamides, am-
picillin, chloramphenicol, nalidixic 
acid, and ciproﬂ  oxacin by using Etest 
(AB bioMérieux, Solna, Sweden) ac-
cording to Clinical and Laboratory 
Standards Institute procedures and in-
terpretative standards for V. cholerae 
(1). PCR ampliﬁ  cation of the genes 
encoding DNA gyrase (gyrA  and 
gyrB) and topoisomerase IV (parC 
and parE) and subsequent sequencing 
of PCR products were performed (2).
PCR was used to test for the pres-
ence of ctxA and ctxB genes, which 
encode the cholera toxin (CT), and the 
tcpA gene, which encodes the toxin-
coregulated pilus. Genotyping of ctxB 
was performed by sequencing PCR 
products.
All isolates showed susceptibility 
to tetracycline (MIC 1.5 mg/L), inter-
mediate susceptibility to ampicillin 
(MICs 12–16 mg/L) and chloramphen-
icol (MICs 8–12 mg/L), and resistance 
to trimethoprim/sulfamethoxazole 
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